Hangzhou Tigermed Consulting Co., Ltd Stock
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.74 CNY | -1.05% |
|
+4.89% | -3.44% |
01-27 | Tigermed Consulting Forecasts Up to 81% Lower Attributable Net Profit for 2024 | MT |
01-24 | Hangzhou Tigermed Consulting Co., Ltd Provides Earnings Guidance for the Year Ended December 31, 2024 | CI |
Capitalization | 41.98B 5.76B 5.51B 5.21B 4.59B 8.18B 499B 9.14B 61.99B 23B 208B 21.57B 21.14B 880B | P/E ratio 2024 * |
94.9x | P/E ratio 2025 * | 25.2x |
---|---|---|---|---|---|
Enterprise value | 36.26B 4.97B 4.76B 4.5B 3.97B 7.07B 431B 7.89B 53.55B 19.87B 180B 18.63B 18.26B 760B | EV / Sales 2024 * |
5.32x | EV / Sales 2025 * | 4.58x |
Free-Float |
72.37% | Yield 2024 * |
0.67% | Yield 2025 * | 0.89% |
1 day | -1.05% | ||
1 week | +4.89% | ||
Current month | +7.63% | ||
1 month | +6.20% | ||
3 months | -21.98% | ||
6 months | -2.75% | ||
Current year | -3.44% |







Director | Title | Age | Since |
---|---|---|---|
Xiao Chun Cao
CEO | Chief Executive Officer | 55 | - |
Cheng Cheng Yang
DFI | Director of Finance/CFO | 51 | 2022-10-20 |
Hao Wu
PSD | President | 57 | 2019-12-31 |
Manager | Title | Age | Since |
---|---|---|---|
Xiao Chun Cao
BRD | Director/Board Member | 55 | 2004-12-31 |
Xiao Ping Ye
CHM | Chairman | 62 | - |
Zhi Min Chen
BRD | Director/Board Member | 65 | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.05% | +4.89% | +23.22% | -40.47% | 5.81B | ||
-0.10% | -2.45% | +35.29% | -2.61% | 47.29B | ||
-0.89% | -6.63% | -8.93% | -19.74% | 34.84B | ||
-0.45% | -1.71% | -0.38% | +22.57% | 26.05B | ||
-0.08% | +4.72% | +73.31% | +81.97% | 16.55B | ||
-2.09% | -6.79% | -33.62% | -30.17% | 15.4B | ||
+4.54% | -5.03% | -62.61% | -80.21% | 11.75B | ||
+13.36% | +28.87% | - | - | 11.63B | ||
-0.99% | -10.99% | -1.11% | -36.19% | 10.66B | ||
+1.77% | -5.14% | -5.96% | +95.77% | 10.25B | ||
Average | +0.20% | -0.54% | +2.14% | -1.01% | 19.02B | |
Weighted average by Cap. | -0.06% | -1.25% | +7.67% | +0.49% |
2024 * | 2025 * | |
---|---|---|
Net sales | 6.82B 935M 896M 846M 746M 1.33B 81.1B 1.48B 10.07B 3.74B 33.76B 3.51B 3.44B 143B | 7.73B 1.06B 1.01B 958M 845M 1.51B 91.86B 1.68B 11.41B 4.23B 38.25B 3.97B 3.89B 162B |
Net income | 1.14B 156M 149M 141M 124M 221M 13.5B 247M 1.68B 622M 5.62B 584M 572M 23.82B | 1.6B 219M 210M 199M 175M 312M 19.03B 348M 2.36B 877M 7.92B 823M 806M 33.57B |
Net Debt | -5.72B -784M -751M -709M -625M -1.11B -67.97B -1.24B -8.44B -3.13B -28.3B -2.94B -2.88B -120B | -6.62B -908M -870M -822M -724M -1.29B -78.76B -1.44B -9.78B -3.63B -32.79B -3.4B -3.34B -139B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-13 | 52.74 ¥ | -1.05% | 9,960,587 |
25-02-12 | 53.30 ¥ | +0.57% | 8,358,500 |
25-02-11 | 53.00 ¥ | -3.07% | 12,594,070 |
25-02-10 | 54.68 ¥ | +5.70% | 21,462,350 |
25-02-07 | 51.73 ¥ | +2.88% | 21,056,220 |
End-of-day quote Shenzhen S.E., February 12, 2025
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300347 Stock

MarketScreener is also available in this country: United States.
Switch edition